Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term

· seekingalpha.com

Abbott stays a buy after Q2 beat/raise; Exact Sciences boosts growth. Click for more on ABT stock.

Formerly known as "The Dividend Collectuh." Top 1% of financial experts on TipRanks. Contributing analyst to the iREIT+Hoya Capital investment group. Dividend C...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI